Cdc25 cell-cycle phosphatase as a target of c-myc

The product of the proto-oncogene c-myc, in partnership with Max, forms a transcription factor that can promote either oncogenic transformation or apoptosis. The Myc/Max heterodimer binds to elements in the cdc25A gene and activates transcription. Like myc, cdc25A, itself a proto-oncogene, can induce apoptosis in cells depleted of growth factor, and Myc-induced apoptosis also requires cdc25A. These findings indicate that cdc25A is a physiologically relevant transcriptional target of c-myc.

[1]  L. Andersson,et al.  Ornithine decarboxylase activity is critical for cell transformation , 1992, Nature.

[2]  G. Evan,et al.  The c‐Myc protein induces cell cycle progression and apoptosis through dimerization with Max. , 1993, The EMBO journal.

[3]  J. Moore,et al.  c-myc protein expression in untransformed fibroblasts. , 1991, Oncogene.

[4]  M. Eilers,et al.  The functions of Myc proteins. , 1992, Biochimica et biophysica acta.

[5]  G. Prendergast,et al.  Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation , 1991, Cell.

[6]  H Nojima,et al.  Cdc25A is a novel phosphatase functioning early in the cell cycle. , 1994, The EMBO journal.

[7]  Bruno Amati,et al.  Oncogenic activity of the c-Myc protein requires dimerization with Max , 1993, Cell.

[8]  M. Pagano,et al.  Identification of a Myc‐dependent step during the formation of active G1 cyclin‐cdk complexes. , 1995, The EMBO journal.

[9]  I. Mazo,et al.  Cloning mammalian genes by expression selection of genetic suppressor elements: association of kinesin with drug resistance and cell immortalization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Eisenman,et al.  Myc and Max proteins possess distinct transcriptional activities , 1992, Nature.

[11]  H. Varmus,et al.  Definition of regions in human c-myc that are involved in transformation and nuclear localization , 1987, Molecular and cellular biology.

[12]  M. Cole,et al.  max encodes a sequence-specific DNA-binding protein and is not regulated by serum growth factors. , 1992, Oncogene.

[13]  K. Alitalo,et al.  myc oncogenes: activation and amplification. , 1987, Biochimica et biophysica acta.

[14]  J. Bishop.  Cellular oncogenes and retroviruses. , 1983, Annual review of biochemistry.

[15]  H. Weintraub,et al.  Sequence-specific DNA binding by the c-Myc protein. , 1990, Science.

[16]  G. Evan,et al.  Max and c-Myc/Max DNA-binding activities in cell extracts. , 1992, Oncogene.

[17]  T. Hunter,et al.  A mouse cdc25 homolog is differentially and developmentally expressed. , 1992, Genes & development.

[18]  K. Sadhu,et al.  Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  L. M. Facchini,et al.  Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. , 1994, Oncogene.

[20]  C. Dang,et al.  Max: functional domains and interaction with c-Myc. , 1992, Genes & development.

[21]  M. Tatsuka,et al.  Requirement for tyrosine phosphorylation of Cdk4 in Gl arrest induced by ultraviolet irradiation , 1995, Nature.

[22]  J. Cleveland,et al.  Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis , 1994, Molecular and cellular biology.

[23]  S Gaubatz,et al.  An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc , 1994, Molecular and cellular biology.

[24]  M. Groudine,et al.  Control of c-myc regulation in normal and neoplastic cells. , 1991, Advances in cancer research.

[25]  N. Hay,et al.  Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. , 1994, Genes & development.

[26]  E. Karsenti,et al.  Activation of the phosphatase activity of human cdc25A by a cdk2‐cyclin E dependent phosphorylation at the G1/S transition. , 1994, The EMBO journal.

[27]  T. Graf,et al.  Three new types of viral oncogene of cellular origin specific for haematopoietic cell transformation , 1979, Nature.

[28]  G. Evan,et al.  Domains of human c-myc protein required for autosuppression and cooperation with ras oncogenes are overlapping , 1990, Molecular and cellular biology.

[29]  L. Desbarats,et al.  Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. , 1996, Genes & development.

[30]  H. Hermeking,et al.  Mediation of c-Myc-induced apoptosis by p53. , 1994, Science.

[31]  A. Patel,et al.  myc function and regulation. , 1992, Annual review of biochemistry.

[32]  M. Loda,et al.  CDC25 phosphatases as potential human oncogenes. , 1995, Science.

[33]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Barrett,et al.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription , 1990, Molecular and cellular biology.

[35]  J L Cleveland,et al.  The ornithine decarboxylase gene is a transcriptional target of c-Myc. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[36]  G. Evan,et al.  Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max , 1992, Nature.

[37]  R. Eisenman,et al.  Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity , 1993, Cell.

[38]  R. Eisenman,et al.  Myc and Max associate in vivo. , 1992, Genes & development.

[39]  L. Penn,et al.  C-MYC: evidence for multiple regulatory functions. , 1990, Seminars in cancer biology.

[40]  D. Beach,et al.  Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: Evidence for multiple roles of mitotic cyclins , 1991, Cell.

[41]  Didier Picard,et al.  Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells , 1989, Nature.

[42]  H. Land,et al.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.

[43]  B. Vennstrom,et al.  Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29 , 1982, Journal of virology.

[44]  D. Beach,et al.  Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation. , 1995, Genes & development.

[45]  J. Cleveland,et al.  c-Myc and apoptosis. , 1995, Biochimica et biophysica acta.

[46]  J. Cleveland,et al.  Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. , 1991, Oncogene.

[47]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.